Last reviewed · How we verify
Progesterone vaginal tablet
Progesterone vaginal tablet is a Small molecule drug developed by Vastra Gotaland Region. It is currently FDA-approved. Also known as: Lutinus, manufactured by Ferring GmbH. ATC code G03DA04.
Progesterone vaginal tablets are a type of small molecule medication that acts as a progesterone receptor agonist. They are used to treat various conditions, including fertility issues, embryo implantation, and endometrial hyperplasia, as well as to support frozen embryo transfer.
At a glance
| Generic name | Progesterone vaginal tablet |
|---|---|
| Also known as | Lutinus, manufactured by Ferring GmbH. ATC code G03DA04 |
| Sponsor | Vastra Gotaland Region |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy (NA)
- Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation (NA)
- The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth: (NA)
- Rescue Progesterone Supplementation During Frozen Embryo Transfer (PHASE2)
- Estrogen Administration for the Treatment of NASH in Postmenopausal Women (PHASE3)
- Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration. (PHASE1)
- Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone (EARLY_PHASE1)
- Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Progesterone vaginal tablet CI brief — competitive landscape report
- Progesterone vaginal tablet updates RSS · CI watch RSS
- Vastra Gotaland Region portfolio CI
Frequently asked questions about Progesterone vaginal tablet
What is Progesterone vaginal tablet?
Who makes Progesterone vaginal tablet?
Is Progesterone vaginal tablet also known as anything else?
What development phase is Progesterone vaginal tablet in?
Related
- Manufacturer: Vastra Gotaland Region — full pipeline
- Also known as: Lutinus, manufactured by Ferring GmbH. ATC code G03DA04
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing